Try
Sarepta Therapeutics, Inc.
SRPTUnited States
79 filed reports · 755 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
79 reports · Dec 2010 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 43 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 46 | 7,122 | Jun 2011 to Jun 2026 |
| Current · 8-KSEC EDGAR | 18 | 43 | Dec 2010 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 15 | 7,419 | Dec 2011 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 486 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 5, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 286 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 6, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 2, 2026 | 1,193 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 331 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 195 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 186 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 28, 2025 | 580 | Open |
| FY2024 Q4 | 8-K | Dec 31, 2024 | Feb 26, 2025 | 2 | Open |
| FY2024 Q4 | 8-K | Dec 31, 2024 | Jan 13, 2025 | 2 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 6, 2024 | 230 | Open |
Financial data
755 concepts · 14,584 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial722 concepts · 14,187 facts · Dec 2008 to Jul 2026
- Manufacturing-related deposits and prepaids91 · Dec 2015 to Jun 2026
- Cash and cash equivalents at carrying value84 · Dec 2008 to Jun 2026
- Net income loss83 · Dec 2009 to Jun 2026
- Nonoperating income expense83 · Dec 2009 to Jun 2026
- Operating income loss83 · Dec 2009 to Jun 2026
- Depreciation depletion and amortization81 · Dec 2009 to Jun 2026
- Payments to acquire property plant and equipment81 · Dec 2009 to Jun 2026
- Share based compensation81 · Dec 2009 to Jun 2026
- Comprehensive income net of tax80 · Dec 2009 to Jun 2026
- Common stock value79 · Dec 2010 to Jun 2026
- Accounts payable current78 · Dec 2010 to Jun 2026
- Accounts receivable net current78 · Dec 2010 to Jun 2026
- Assets78 · Dec 2010 to Jun 2026
- Assets current78 · Dec 2010 to Jun 2026
- Common stock par or stated value per share78 · Dec 2010 to Jun 2026
- Common stock shares authorized78 · Dec 2010 to Jun 2026
- Common stock shares issued78 · Dec 2010 to Jun 2026
- Common stock shares outstanding78 · Dec 2010 to Jun 2026
- Employee related liabilities current78 · Dec 2010 to Jun 2026
- Finite lived intangible assets net78 · Dec 2010 to Jun 2026
- Liabilities and stockholders equity78 · Dec 2010 to Jun 2026
- Liabilities current78 · Dec 2010 to Jun 2026
- Other assets current78 · Dec 2010 to Jun 2026
- Other assets noncurrent78 · Dec 2010 to Jun 2026
Segment20 concepts · 201 facts · Dec 2022 to Jun 2026
- Cost of sales (excluding amortization of in-licensed rights)14 · Dec 2022 to Jun 2026
- Interest expense (US GAAP)14 · Dec 2022 to Jun 2026
- Manufacturing costs14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Other research and development expense14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Selling general and administrative expense14 · Dec 2022 to Jun 2026
- Gain loss on investments13 · Dec 2023 to Jun 2026
- Operating Segments13 · Dec 2023 to Jun 2026
- Share based compensation13 · Dec 2023 to Jun 2026
- Operating Segments Member12 · Dec 2022 to Jun 2026
- Depreciation depletion and amortization8 · Mar 2024 to Jun 2026
- Gains losses on extinguishment of debt8 · Dec 2022 to Dec 2025
- Income tax expense benefit8 · Mar 2024 to Jun 2026
- Investment income interest8 · Mar 2024 to Jun 2026
- Restructuring charges7 · Dec 2023 to Dec 2025
- Depreciation and amortization4 · Dec 2022 to Dec 2025
- Interest income other4 · Dec 2022 to Dec 2025
- Allocated share based compensation expense3 · Dec 2022 to Dec 2024
- Litigation settlement expense2 · Jun 2025 to Jun 2026
Product4 concepts · 133 facts · Sep 2016 to Jun 2026
- Revenue121 · Mar 2020 to Jun 2026
- EXONDYS 5110 · Dec 2019 to Dec 2022
- Allocated share based compensation expense1 · Sep 2016
- Amortization of intangible assets1 · Dec 2017
Guidance4 concepts · 43 facts · Mar 2011 to Aug 2026
- Revenue Guidance27 · Mar 2011 to Aug 2026
- Operating Income Guidance12 · Mar 2012 to Nov 2014
- Capital Expenditures Guidance2 · Aug 2014
- Revenue Growth Guidance2 · Jan 2018
Geography5 concepts · 20 facts · Jun 2022 to Dec 2025
- Revenue8 · Jun 2022 to Jun 2023
- Effective income tax rate reconciliation cross border other amount3 · Dec 2023 to Dec 2025
- Effective income tax rate reconciliation cross border other percent3 · Dec 2023 to Dec 2025
- Effective income tax rate reconciliation foreign income tax rate differential3 · Dec 2023 to Dec 2025
- Income tax reconciliation foreign income tax rate differential3 · Dec 2023 to Dec 2025
Segments
354 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 201 facts
- All Other Segments201 · Dec 2022 to Jun 2026
Product or servicesrt:ProductOrServiceAxis7 members · 131 facts
- Pmo Products63 · Sep 2022 to Jun 2026
- Elevidys42 · Sep 2022 to Jun 2026
- EXONDYS Fifty One10 · Dec 2019 to Dec 2022
- VYONDYS Fifty Three10 · Dec 2019 to Dec 2022
- AMONDYS Fourty Five4 · Sep 2020 to Sep 2021
- Amondys451 · Dec 2022
- Vyondys Forty Five1 · Dec 2021
Statement geographical3 members · 20 facts
- IE12 · Dec 2023 to Dec 2025
- Non Us4 · Jun 2022 to Jun 2023
- US4 · Jun 2022 to Jun 2023
Product or serviceus-gaap:ProductOrServiceAxis1 member · 2 facts
- EXONDYS Fifty One2 · Sep 2016 to Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.